Spain ranks among the world’s top three in clinical trials, with 930 authorized in 2024, notably in oncology. Its strength lies in 19 cooperative groups of...
Bladder cancer treatment has advanced significantly, doubling survival in some stages. In Spain, experts urge improved access and multidisciplinary care. The II Bladder Cancer Conference stressed...
With this analysis, they can deduce the aggressiveness of adenocarcinoma and leiomyosarcoma uterine tumors. The starting point was a previous study in which the same tools...
Pharma Mar has other programs in the clinical development phase for various types of solid tumors: lurbinectedin, and ecubectedin. Headquartered in Madrid, the group has subsidiaries...